Pay in 4 interest-free payments of $5.16 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
The Triple Threat: Retatrutides Glucagon Component Retatrutide is often referred to as a GIP GLP-1 Glucagon agonist , setting it apart as the first drug of its kind to target three distinct metabolic pathways
It typically occurs 10 to 30 minutes after injection and lasts 30 minutes to 2 hours
Your body relies on it every day
Patients should not overlap an investigational retatrutide product with tirzepatide unless they are participating in an authorized clinical study with appropriate oversight
Advertisement Article continues below this ad Inside Eli Lilly's $6.5 billion Houston bet Eli Lilly announced in September that it would build the sprawling pharmaceutical campus at Generation Park, marking one of the largest manufacturing investments in Houston history
GLP-1 drugs have ushered in a new era in weight loss
